MedTrace Logo

Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity

NCT02918279 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 251

Last updated 2020-04-27

Study results available
· View outcomes & findings →

Summary

This trial is conducted globally. The aim of this trial is to investigate the effect of liraglutide for weight management in pubertal adolescent subjects with obesity.

Conditions

  • Metabolism and Nutrition Disorder
  • Obesity

Interventions

DRUG

Liraglutide

Administered once daily subcutaneously (s.c., under the skin)

DRUG

Placebo

Administered once daily subcutaneously (s.c., under the skin)

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR) · Novo Nordisk A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-29
Primary Completion
2019-02-14
Completion
2019-08-08

Countries

  • United States
  • Belgium
  • Mexico
  • Russia
  • Sweden

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02918279 on ClinicalTrials.gov